Cargando…

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial

BACKGROUND: In polypharmacy patients under home health management, pharmacogenetic testing coupled with guidance from a clinical decision support tool (CDST) on reducing drug, gene, and cumulative interaction risk may provide valuable insights in prescription drug treatment, reducing re-hospitalizat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliott, Lindsay S., Henderson, John C., Neradilek, Moni B., Moyer, Nicolas A., Ashcraft, Kristine C., Thirumaran, Ranjit K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289536/ https://www.ncbi.nlm.nih.gov/pubmed/28151991 http://dx.doi.org/10.1371/journal.pone.0170905

Ejemplares similares

Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients
por: Kim, Kibum, et al.
Publicado: (2018)

Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study
por: Finkelstein, Joseph, et al.
Publicado: (2016)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy
por: Sugarman, Elaine A., et al.
Publicado: (2016)

Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
por: Jessop, Jayson P., et al.
Publicado: (2023)

Proposal for a Pharmacogenetic Decision Algorithm
por: Alzghari, Saeed K, et al.
Publicado: (2017)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report
por: Smith, Teri, et al.
Publicado: (2015)

FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy
por: Roncato, Rossana, et al.
Publicado: (2019)

Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis
por: Plant, Jon D., et al.
Publicado: (2017)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity
por: Sallevelt, Bastiaan T. G. M., et al.
Publicado: (2021)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
por: Pandya, Dehuti, et al.
Publicado: (2020)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
por: Keine, Dorothy, et al.
Publicado: (2019)

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial
por: Shah-Williams, Ebony, et al.
Publicado: (2020)

Medication management at home in older patients with polypharmacy: In-depth interviews with home visits
por: Vatcharavongvan, Pasitpon, et al.
Publicado: (2022)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014)

Digital Health Applications for Pharmacogenetic Clinical Trials
por: Naik, Hetanshi, et al.
Publicado: (2020)

Encountering Pharmacogenetic Test Results in the Psychiatric Clinic
por: Bousman, Chad A, et al.
Publicado: (2021)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
por: Huang, Chunmei, et al.
Publicado: (2011)

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population
por: Ashcraft, Kristine, et al.
Publicado: (2022)

Excessive polypharmacy and potentially inappropriate prescribing in 147 care homes: a cross-sectional study
por: MacRae, Clare, et al.
Publicado: (2021)

Rates, variability, and associated factors of polypharmacy in nursing home patients
por: Beloosesky, Yichayaou, et al.
Publicado: (2013)

A path analysis of the effects of the doctor-patient encounter and expectancy in an open-label randomized trial of spinal manipulation for the care of low back pain
por: Haas, Mitchell, et al.
Publicado: (2014)

Prediction of pain outcomes in a randomized controlled trial of dose–response of spinal manipulation for the care of chronic low back pain
por: Vavrek, Darcy, et al.
Publicado: (2015)

P450 Pharmacogenetics in Indigenous North American Populations
por: Henderson, Lindsay M., et al.
Publicado: (2018)

Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care
por: Mitchell, Sabrina L, et al.
Publicado: (2020)

LONG TERM CARE FEASIBILITY OF NURSING HOME LVNS USING AN ALGORITHM-GUIDED ASSESSMENT SUPPORT TOOL
por: Ashcraft, Alyce S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b33r8djine19tuadtbcfdbc23u